Morgan Stanley has initiated coverage on Waters Corp (WAT) with an Equal-Weight rating as of December 1, 2025. This marks the firm's first assessment of the company, which operates in the Life Sciences Tools & Services industry. Waters Corp, headquartered in Milford, Massachusetts, provides workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis, employing approximately 7,600 full-time staff.
The company's market capitalization stands at $23.5 billion, with a P/E ratio of 36.15 and an EPS of 10.87. Analyst consensus indicates a Buy rating, with 4 Strong Buy, 6 Buy, 11 Hold, 0 Sell, and 0 Strong Sell ratings among 21 analysts.
This update provides insight into the firm's perspective on Waters Corp's investment merit, reflecting their research and analysis of the business and industry dynamics. Analyst ratings can evolve as new information becomes available, and various analysts may hold differing views on the same company.
Recent analyst actions include Wells Fargo maintaining an Equal-Weight rating and TD Cowen holding its position at Hold, both as of November 5, 2025. JP Morgan also maintained a Neutral rating on October 9, 2025, while Rothschild & Co initiated coverage with a Buy rating on October 8, 2025.